Selected research
Industry Research
Constipation Nutraceuticals Industry Research Report 2026
Market perspective
The global Constipation Nutraceuticals market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Constipation Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Constipation Nutraceuticals is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Constipation Nutraceuticals is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Constipation Nutraceuticals include Tate & Lyle, Kerry Group, Ingredion Incorporated, Glanbia, DuPont, DSM, Chr. Hansen Holding, Cargill and BASF, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Constipation Nutraceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Constipation Nutraceuticals Market by Company
Tate & Lyle
Kerry Group
Ingredion Incorporated
Glanbia
DuPont
DSM
Chr. Hansen Holding
Cargill
BASF
Associated British Foods
Arla Foods
Ajinomoto Group
ADM
Constipation Nutraceuticals Segment by Type
Omega-3 Fatty Acids
Amino Acids and Proteins
Minerals
Carotenoids
Vitamins
Fibers and Specialty Carbohydrates
Prebiotics and Probiotics
Others
Constipation Nutraceuticals Segment by Application
Adult
Child
Constipation Nutraceuticals Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Constipation Nutraceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Constipation Nutraceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Constipation Nutraceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Constipation Nutraceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Constipation Nutraceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Constipation Nutraceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Omega-3 Fatty Acids
- Amino Acids and Proteins
- Minerals
- Carotenoids
- Vitamins
- Fibers and Specialty Carbohydrates
- Prebiotics and Probiotics
- Others
Applications
- Adult
- Child
Companies covered
- Tate & Lyle
- Kerry Group
- Ingredion Incorporated
- Glanbia
- DuPont
- DSM
- Chr. Hansen Holding
- Cargill
- BASF
- Associated British Foods
- Arla Foods
- Ajinomoto Group
- ADM
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Constipation Nutraceuticals Market Size (2021-2032)
- 2.2.2 Global Constipation Nutraceuticals Sales (2021-2032)
- 2.2.3 Global Constipation Nutraceuticals Market Average Price (2021-2032)
- 2.3 Constipation Nutraceuticals by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Omega-3 Fatty Acids
- 2.3.3 Amino Acids and Proteins
- 2.3.4 Minerals
- 2.3.5 Carotenoids
- 2.3.6 Vitamins
- 2.3.7 Fibers and Specialty Carbohydrates
- 2.3.8 Prebiotics and Probiotics
- 2.3.9 Others
- 2.4 Constipation Nutraceuticals by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Child
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Constipation Nutraceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Constipation Nutraceuticals Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Constipation Nutraceuticals Revenue of Manufacturers (2021-2026)
- 3.4 Global Constipation Nutraceuticals Average Price by Manufacturers (2021-2026)
- 3.5 Global Constipation Nutraceuticals Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Constipation Nutraceuticals, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Constipation Nutraceuticals, Product Type & Application
- 3.8 Global Manufacturers of Constipation Nutraceuticals, Established Date
- 3.9 Global Constipation Nutraceuticals Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tate & Lyle
- 4.1.1 Tate & Lyle Company Information
- 4.1.2 Tate & Lyle Business Overview
- 4.1.3 Tate & Lyle Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tate & Lyle Constipation Nutraceuticals Product Portfolio
- 4.1.5 Tate & Lyle Recent Developments
- 4.2 Kerry Group
- 4.2.1 Kerry Group Company Information
- 4.2.2 Kerry Group Business Overview
- 4.2.3 Kerry Group Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kerry Group Constipation Nutraceuticals Product Portfolio
- 4.2.5 Kerry Group Recent Developments
- 4.3 Ingredion Incorporated
- 4.3.1 Ingredion Incorporated Company Information
- 4.3.2 Ingredion Incorporated Business Overview
- 4.3.3 Ingredion Incorporated Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ingredion Incorporated Constipation Nutraceuticals Product Portfolio
- 4.3.5 Ingredion Incorporated Recent Developments
- 4.4 Glanbia
- 4.4.1 Glanbia Company Information
- 4.4.2 Glanbia Business Overview
- 4.4.3 Glanbia Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Glanbia Constipation Nutraceuticals Product Portfolio
- 4.4.5 Glanbia Recent Developments
- 4.5 DuPont
- 4.5.1 DuPont Company Information
- 4.5.2 DuPont Business Overview
- 4.5.3 DuPont Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DuPont Constipation Nutraceuticals Product Portfolio
- 4.5.5 DuPont Recent Developments
- 4.6 DSM
- 4.6.1 DSM Company Information
- 4.6.2 DSM Business Overview
- 4.6.3 DSM Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 DSM Constipation Nutraceuticals Product Portfolio
- 4.6.5 DSM Recent Developments
- 4.7 Chr. Hansen Holding
- 4.7.1 Chr. Hansen Holding Company Information
- 4.7.2 Chr. Hansen Holding Business Overview
- 4.7.3 Chr. Hansen Holding Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chr. Hansen Holding Constipation Nutraceuticals Product Portfolio
- 4.7.5 Chr. Hansen Holding Recent Developments
- 4.8 Cargill
- 4.8.1 Cargill Company Information
- 4.8.2 Cargill Business Overview
- 4.8.3 Cargill Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cargill Constipation Nutraceuticals Product Portfolio
- 4.8.5 Cargill Recent Developments
- 4.9 BASF
- 4.9.1 BASF Company Information
- 4.9.2 BASF Business Overview
- 4.9.3 BASF Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BASF Constipation Nutraceuticals Product Portfolio
- 4.9.5 BASF Recent Developments
- 4.10 Associated British Foods
- 4.10.1 Associated British Foods Company Information
- 4.10.2 Associated British Foods Business Overview
- 4.10.3 Associated British Foods Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Associated British Foods Constipation Nutraceuticals Product Portfolio
- 4.10.5 Associated British Foods Recent Developments
- 4.11 Arla Foods
- 4.11.1 Arla Foods Company Information
- 4.11.2 Arla Foods Business Overview
- 4.11.3 Arla Foods Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Arla Foods Constipation Nutraceuticals Product Portfolio
- 4.11.5 Arla Foods Recent Developments
- 4.12 Ajinomoto Group
- 4.12.1 Ajinomoto Group Company Information
- 4.12.2 Ajinomoto Group Business Overview
- 4.12.3 Ajinomoto Group Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ajinomoto Group Constipation Nutraceuticals Product Portfolio
- 4.12.5 Ajinomoto Group Recent Developments
- 4.13 ADM
- 4.13.1 ADM Company Information
- 4.13.2 ADM Business Overview
- 4.13.3 ADM Constipation Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ADM Constipation Nutraceuticals Product Portfolio
- 4.13.5 ADM Recent Developments
5 Global Constipation Nutraceuticals Market Scenario by Region
- 5.1 Global Constipation Nutraceuticals Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Constipation Nutraceuticals Sales by Region: 2021-2032
- 5.2.1 Global Constipation Nutraceuticals Sales by Region: 2021-2026
- 5.2.2 Global Constipation Nutraceuticals Sales by Region: 2027-2032
- 5.3 Global Constipation Nutraceuticals Revenue by Region: 2021-2032
- 5.3.1 Global Constipation Nutraceuticals Revenue by Region: 2021-2026
- 5.3.2 Global Constipation Nutraceuticals Revenue by Region: 2027-2032
- 5.4 North America Constipation Nutraceuticals Market Facts & Figures by Country
- 5.4.1 North America Constipation Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Constipation Nutraceuticals Sales by Country (2021-2032)
- 5.4.3 North America Constipation Nutraceuticals Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Constipation Nutraceuticals Market Facts & Figures by Country
- 5.5.1 Europe Constipation Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Constipation Nutraceuticals Sales by Country (2021-2032)
- 5.5.3 Europe Constipation Nutraceuticals Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Constipation Nutraceuticals Market Facts & Figures by Country
- 5.6.1 Asia Pacific Constipation Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Constipation Nutraceuticals Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Constipation Nutraceuticals Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Constipation Nutraceuticals Market Facts & Figures by Country
- 5.7.1 South America Constipation Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Constipation Nutraceuticals Sales by Country (2021-2032)
- 5.7.3 South America Constipation Nutraceuticals Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Constipation Nutraceuticals Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Constipation Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Constipation Nutraceuticals Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Constipation Nutraceuticals Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Constipation Nutraceuticals Sales by Type (2021-2032)
- 6.1.1 Global Constipation Nutraceuticals Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Constipation Nutraceuticals Sales Market Share by Type (2021-2032)
- 6.2 Global Constipation Nutraceuticals Revenue by Type (2021-2032)
- 6.2.1 Global Constipation Nutraceuticals Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Constipation Nutraceuticals Revenue Market Share by Type (2021-2032)
- 6.3 Global Constipation Nutraceuticals Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Constipation Nutraceuticals Sales by Application (2021-2032)
- 7.1.1 Global Constipation Nutraceuticals Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Constipation Nutraceuticals Sales Market Share by Application (2021-2032)
- 7.2 Global Constipation Nutraceuticals Revenue by Application (2021-2032)
- 7.2.1 Global Constipation Nutraceuticals Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Constipation Nutraceuticals Revenue Market Share by Application (2021-2032)
- 7.3 Global Constipation Nutraceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Constipation Nutraceuticals Value Chain Analysis
- 8.1.1 Constipation Nutraceuticals Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Constipation Nutraceuticals Production Mode & Process
- 8.2 Constipation Nutraceuticals Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Constipation Nutraceuticals Distributors
- 8.2.3 Constipation Nutraceuticals Customers
9 Global Constipation Nutraceuticals Analyzing Market Dynamics
- 9.1 Constipation Nutraceuticals Industry Trends
- 9.2 Constipation Nutraceuticals Industry Drivers
- 9.3 Constipation Nutraceuticals Industry Opportunities and Challenges
- 9.4 Constipation Nutraceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst